引用本文: | 徐菲, 李培勇. 瑞波西利联合内分泌治疗用于绝经前侵袭性HR+/HER2-晚期乳腺癌患者:随机Ⅱ期RIGHT Choice试验[J]. 循证医学, 2023, 23(2): 92-95. DOI: 10.12019/j.issn.1671-5144.2023.02.006 |
Citation: | XU Fei, LI Pei-yong. Randomized Phase Ⅱ RIGHT Choice Trial of Premenopausal Patients With Aggressive HR+/HER2- Advanced Breast Cancer Treated With Ribociclib and Endocrine Therapy[J]. Journal of Evidence-Based Medicine, 2023, 23(2): 92-95. DOI: 10.12019/j.issn.1671-5144.2023.02.006 |